Literature DB >> 28346091

A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.

Madhu Lal-Nag1, Lauren McGee1, Rajarshi Guha1, Ernst Lengyel2, Hilary A Kenny2, Marc Ferrer1.   

Abstract

The tumor microenvironment plays an important role in the processes of tumor growth, metastasis, and drug resistance. We have used a multilayered 3D primary cell culture model that reproduces the human ovarian cancer metastatic microenvironment to study the effect of the microenvironment on the pharmacological responses of different classes of drugs on cancer cell proliferation. A collection of oncology drugs was screened to identify compounds that inhibited the proliferation of ovarian cancer cells growing as monolayers or forming spheroids, on plastic and on a 3D microenvironment culture model of the omentum metastatic site, and also cells already in preformed spheroids. Target-based analysis of the pharmacological responses revealed that several classes of targets were more efficacious in cancer cells growing in the absence of the metastatic microenvironment, and other target classes were less efficacious in cancer cells in preformed spheres compared to forming spheroid cultures. These findings show that both the cellular context of the tumor microenvironment and cell adhesion mode have an essential role in cancer cell drug resistance. Therefore, it is important to perform screens for new drugs using model systems that more faithfully recapitulate the tissue composition at the site of tumor growth and metastasis.

Entities:  

Keywords:  cell growth; drug resistance; drug responses; high-throughput screening (HTS); tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28346091      PMCID: PMC5815521          DOI: 10.1177/2472555216687082

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  31 in total

1.  Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance.

Authors:  R E SCULLY; G S RICHARDSON
Journal:  Cancer       Date:  1961 Jul-Aug       Impact factor: 6.860

2.  Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation.

Authors:  Zi Fang; Tao Zhang; Nishtman Dizeyi; Sen Chen; Hongyun Wang; Kenneth D Swanson; Changmeng Cai; Steven P Balk; Xin Yuan
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

Review 3.  The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance.

Authors:  K H Shain; T H Landowski; W S Dalton
Journal:  Curr Opin Oncol       Date:  2000-11       Impact factor: 3.645

4.  Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.

Authors:  Hilary A Kenny; Madhu Lal-Nag; Erin A White; Min Shen; Chun-Yi Chiang; Anirban K Mitra; Yilin Zhang; Marion Curtis; Elizabeth M Schryver; Sam Bettis; Ajit Jadhav; Matthew B Boxer; Zhuyin Li; Marc Ferrer; Ernst Lengyel
Journal:  Nat Commun       Date:  2015-02-05       Impact factor: 14.919

Review 5.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

Review 6.  The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.

Authors:  Douglas W McMillin; Joseph M Negri; Constantine S Mitsiades
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

7.  Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.

Authors:  Jürgen Sonnemann; Isabel Hüls; Michael Sigler; Chithra D Palani; Le Thi Thu Hong; Uwe Völker; Heyo K Kroemer; James F Beck
Journal:  Oncol Rep       Date:  2008-07       Impact factor: 3.906

8.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.

Authors:  Hilary A Kenny; Chun-Yi Chiang; Erin A White; Elizabeth M Schryver; Mohammed Habis; Iris L Romero; Andras Ladanyi; Carla V Penicka; Joshy George; Karl Matlin; Anthony Montag; Kristen Wroblewski; S Diane Yamada; Andrew P Mazar; David Bowtell; Ernst Lengyel
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

9.  Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.

Authors:  Shane K Green; Giulio Francia; Ciro Isidoro; Robert S Kerbel
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

10.  Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.

Authors:  Kristy Shield; Clyde Riley; Michael A Quinn; Gregory E Rice; Margaret L Ackland; Nuzhat Ahmed
Journal:  J Carcinog       Date:  2007-06-14
View more
  11 in total

1.  Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.

Authors:  Hilary A Kenny; Madhu Lal-Nag; Min Shen; Betul Kara; Dominik A Nahotko; Kristen Wroblewski; Sarah Fazal; Siquan Chen; Chun-Yi Chiang; Yen-Ju Chen; Kyle R Brimacombe; Juan Marugan; Marc Ferrer; Ernst Lengyel
Journal:  Mol Cancer Ther       Date:  2019-09-27       Impact factor: 6.261

2.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

3.  Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.

Authors:  Sean McGuire; Betul Kara; Peter C Hart; Anthony Montag; Kristen Wroblewski; Sarah Fazal; Xin-Yun Huang; Ernst Lengyel; Hilary A Kenny
Journal:  Gynecol Oncol       Date:  2019-02-20       Impact factor: 5.482

4.  Identification of the polyether ionophore lenoremycin through a new screening strategy for targeting cancer stem cells.

Authors:  Hiroaki Ikeda; Misato Kawami; Masaya Imoto; Hideaki Kakeya
Journal:  J Antibiot (Tokyo)       Date:  2022-10-08       Impact factor: 3.424

5.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.

Authors:  Guido Gambara; Manuela Gaebler; Ulrich Keilholz; Christian R A Regenbrecht; Alessandra Silvestri
Journal:  Front Pharmacol       Date:  2018-02-14       Impact factor: 5.810

Review 7.  Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment.

Authors:  Karen M Watters; Preety Bajwa; Hilary A Kenny
Journal:  Cancers (Basel)       Date:  2018-08-09       Impact factor: 6.639

Review 8.  Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.

Authors:  Christine Yee; Kristie-Ann Dickson; Mohammed N Muntasir; Yue Ma; Deborah J Marsh
Journal:  Front Bioeng Biotechnol       Date:  2022-02-10

Review 9.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

10.  Time-lapse imaging of HeLa spheroids in soft agar culture provides virtual inner proliferative activity.

Authors:  Reiko Minamikawa-Tachino; Kiyoshi Ogura; Ayane Ito; Katsuya Nagayama
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.